VYNE Therapeutics Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
10/10
|
2.79 | 57.27 | -95.13% | 0.5199 | +436.69% |
| P/S |
|
62.99 | 33.44 | 88.41% |
|
|
| P/BV |
|
0.301 | 4.64 | -93.52% |
|
|
| P/FCF |
|
-0.6156 | 42.53 | -101.45% |
|
|
| Ev/Ebitda |
|
0.1282 | -17.68 | -100.73% |
|
|
| Ev/S |
|
-8.84 | 22.59 | -139.15% |
|
|
| Ev/FCF |
|
0.148 | 47.55 | -99.69% |
|
|
| E/P |
|
-1.82 | 0.0182 | -10100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-6900.47 | -14.2 | 48482.06% | -4394.24 | +57.03% |
| ROE |
|
-32.06 | 9.78 | -427.76% |
|
|
| ROA |
|
-29.13 | 0.33 | -8924.84% |
|
|
| ROIC |
|
-111.75 | 7.63 | -1563.78% |
|
|
| ROS |
|
-6710.38 | -26.41 | 25304.8% |
|
|
| ROCE |
|
-38.65 | 14.55 | -365.65% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0073 | -3.87 | -99.81% | -0.0075 | -1.87% |
| Nеt Debt/Ebitda |
|
1.04 | -4.24 | -124.55% |
|
|
| Debt/Ratio |
|
0.0022 | 0.1853 | -98.82% |
|
|
| Debt/Equity |
|
0.0056 | 1.61 | -99.65% |
|
|
| Debt/Net Income |
|
-0.0075 | 10.06 | -100.07% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5351 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2368 | -100% |
|
|
| Average dividend growth |
|
0 | 1.48 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4863 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.64 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5351 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-76.44 | 30.62 | -349.64% | ||
| Growth impulse Ebitda in 5 years |
|
-61.6 | -17.42 | 253.62% | ||
| Growth impulse Net Income in 5 years |
|
-59.64 | -52.26 | 14.12% | ||
| Growth impulse FCF in 5 years |
|
-61.07 | -31.68 | 92.77% | ||
| Growth impulse EPS in 5 years |
|
-98.7 | -61.82 | 59.66% |
IP Score
3.2/10
